Found 52 results in Expert Content

Summary: In this executive summary, we describe the benefits of controlled release, how to determine whether a drug is suitable for controlled release and more.

Summary: Experts provide an overview of why the properties and structure of pectin are well suited for site-specific delivery to the colon.

Summary: To rapidly screen macromolecules’ potential for oral delivery, it is critical to assess multiple enabling technologies in parallel, targeting different biological barriers.

This executive summary includes evidence on how the right guidance at the right time can help you create more successful treatments.

Summary: OptiDose Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders.

Summary: Experts will share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications.

Summary: Experts use case studies to demonstrate how the right guidance, at the right time, can help drug developers create better treatments.

Summary: Experts introduce Catalent’s new OptiDose™ Design Solution, an integrated dose form design strategy based on an analyzation of your molecule, patient, and market.

Summary: OneXpress is a single integrated solution that provides the fastest pathway from clinical development to commercial manufacturing. By taking a proactive approach and assessing production considerations early in development, our teams...

Summary: Explore how you can leverage Catalent’s successful track record optimizing thousands of molecules, deep development expertise and broadest set of superior technologies to...